These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18940248)

  • 1. Identification of PP2A as a novel interactor and regulator of TRIP-Br1.
    Zang ZJ; Gunaratnam L; Cheong JK; Lai LY; Hsiao LL; O'Leary E; Sun X; Salto-Tellez M; Bonventre JV; Hsu SI
    Cell Signal; 2009 Jan; 21(1):34-42. PubMed ID: 18940248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation.
    Kranias G; Watt LF; Carpenter H; Holst J; Ludowyke R; Strack S; Sim AT; Verrills NM
    Cell Signal; 2010 Dec; 22(12):1882-90. PubMed ID: 20688157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
    Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
    EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein.
    Voorhoeve PM; Hijmans EM; Bernards R
    Oncogene; 1999 Jan; 18(2):515-24. PubMed ID: 9927208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
    Martín-Encabo S; Santos E; Guerrero C
    Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
    Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R
    Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1.
    Gupta S; Takhar PP; Degenkolbe R; Koh CH; Zimmermann H; Yang CM; Guan Sim K; Hsu SI; Bernard HU
    Virology; 2003 Dec; 317(1):155-64. PubMed ID: 14675634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.
    Vera J; Jaumot M; Estanyol JM; Brun S; Agell N; Bachs O
    Oncogene; 2006 Jan; 25(2):260-70. PubMed ID: 16170352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domains necessary for Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12 a novel regulatory subunit of PP2A?
    Zhu D; Tate RI; Ruediger R; Meigs TE; Denker BM
    Mol Pharmacol; 2007 May; 71(5):1268-76. PubMed ID: 17303700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A.
    Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC
    Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation.
    Chen J; St-Germain JR; Li Q
    Mol Cell Biol; 2005 Jan; 25(2):525-32. PubMed ID: 15632055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of nucleoredoxin with protein phosphatase 2A.
    Lechward K; Sugajska E; de Baere I; Goris J; Hemmings BA; Zolnierowicz S
    FEBS Lett; 2006 Jun; 580(15):3631-7. PubMed ID: 16764867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role for the protein phosphatase 2A B'α regulatory subunit in dephosphorylation of sphingosine kinase 1.
    Pitman MR; Barr RK; Gliddon BL; Magarey AM; Moretti PA; Pitson SM
    Int J Biochem Cell Biol; 2011 Mar; 43(3):342-7. PubMed ID: 21075214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
    Sim KG; Zang Z; Yang CM; Bonventre JV; Hsu SI
    Cell Cycle; 2004 Oct; 3(10):1296-304. PubMed ID: 15467469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of okadaic acid-induced phosphorylation events by a mass spectrometry approach.
    Hill JJ; Callaghan DA; Ding W; Kelly JF; Chakravarthy BR
    Biochem Biophys Res Commun; 2006 Apr; 342(3):791-9. PubMed ID: 16499873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment.
    Guénin S; Schwartz L; Morvan D; Steyaert JM; Poignet A; Madelmont JC; Demidem A
    Int J Oncol; 2008 Jan; 32(1):49-57. PubMed ID: 18097542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression.
    Sim KG; Cheong JK; Hsu SI
    Cell Cycle; 2006 May; 5(10):1111-5. PubMed ID: 16721052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1.
    Bengtsson L; Schwappacher R; Roth M; Boergermann JH; Hassel S; Knaus P
    J Cell Sci; 2009 Apr; 122(Pt 8):1248-57. PubMed ID: 19339557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of active protein phosphatase 2A is coupled to holoenzyme assembly.
    Hombauer H; Weismann D; Mudrak I; Stanzel C; Fellner T; Lackner DH; Ogris E
    PLoS Biol; 2007 Jun; 5(6):e155. PubMed ID: 17550305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.
    Zang ZJ; Sim KG; Cheong JK; Yang CM; Yap CS; Hsu SI
    Cancer Biol Ther; 2007 May; 6(5):712-8. PubMed ID: 17507796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.